Chronic lower back pain affects millions of people worldwide, limiting their daily activities and reducing their quality of life. Traditional pain management often relies on opioids, which come with significant risks including addiction and serious side effects.

A new study published in Nature Medicine offers promising evidence that a standardized cannabis extract could provide an effective alternative for managing this debilitating condition.

The research, conducted by German scientists across multiple medical centers, is one of the more substantial clinical trials examining cannabis for chronic pain management. The findings suggest that full-spectrum cannabis extract can significantly reduce back pain while avoiding the safety concerns associated with conventional opioid treatments.

The Study Behind the Findings

Researchers from several German medical institutions, including Hannover Medical School and Jena University Hospital, conducted a phase 3 clinical trial involving 820 adults with chronic lower back pain. This study followed what is considered the gold standard for medical research—a randomized, double-blind, placebo-controlled design that eliminates bias and ensures reliable results.

The participants, averaging 52 years of age with 56.6% being female, all suffered from chronic lower back pain that had persisted despite conventional treatments. The study divided participants into two groups: 394 received the cannabis extract while 426 received a placebo. Neither the patients nor the researchers knew who was receiving which treatment until after the study concluded.

The trial lasted 12 weeks, with patients taking the medication daily. Researchers carefully monitored pain levels using an 11-point numeric rating scale, where 0 represents no pain and 10 represents the worst possible pain. They also tracked secondary measures including sleep quality, physical function, and the need for rescue medications.

Study Used Full-Spectrum Cannabis Extract

The cannabis extract used in this study wasn’t your typical dispensary product. Researchers used VER-01, a standardized full-spectrum extract derived from a specific Cannabis sativa strain called DKJ127. This pharmaceutical-grade formulation contains precise amounts of various cannabis compounds, including THC (the psychoactive component), cannabigerol, and cannabidiol.

Each dose delivered 2.5 mg of THC—a much lower amount than what’s typically found in recreational cannabis products. The microdose approach aimed to provide therapeutic benefits while minimizing psychoactive effects. The extract was administered orally using a dosing syringe, mixed with sesame oil for better absorption.

The full-spectrum nature of this extract is significant because it contains multiple cannabis compounds working together, a phenomenon called the entourage effect. This approach differs from isolated compounds and may explain why the extract proved effective for pain management.

Cannabis Offers Remarkable Back Pain Relief

The study results were impressive and statistically significant. Patients taking the cannabis extract experienced an average pain reduction of 1.9 points on the 11-point scale after 12 weeks of treatment. In comparison, those taking the placebo saw their pain decrease by only 1.4 points. While this might seem like a modest difference, the 0.5-point additional reduction is meaningful pain relief for people living with chronic pain conditions.

Beyond pain reduction, participants reported improvements in other areas that significantly impact quality of life. Sleep quality improved among those taking the cannabis extract, which is particularly important since chronic pain often disrupts sleep patterns, creating a cycle where poor sleep worsens pain perception.

Physical function also showed marked improvement. Patients found they could move more easily and participate in daily activities that had previously been limited by pain. Many reported being able to return to activities they had avoided due to their back pain, suggesting the treatment’s benefits extended beyond simple pain scores to real-world functionality.

The benefits persisted over time. Participants who continued treatment in a six-month extension phase maintained their pain reductions, indicating that the full spectrum cannabis extract’s effectiveness didn’t diminish with longer use—a common problem with many experienced in their pain medications.

Safety Profile and Side Effects

One of the most encouraging aspects of this study was the safety profile of the cannabis extract. Unlike opioids, which carry significant risks of addiction, overdose, and severe withdrawal symptoms, the cannabis extract showed no signs of dependency or abuse potential among study participants.

The most common side effects were relatively mild and included dizziness, headache, fatigue, and nausea. While these effects led to 17% of participants discontinuing the treatment early, researchers noted this dropout rate was actually lower than what’s typically seen with opioid medications. Traditional pain medications often cause constipation, severe drowsiness, respiratory depression, and carry substantial addiction risks.

Importantly, the study found no evidence of cannabis use disorder, withdrawal symptoms, or drug-seeking behavior among participants. The company who sponsored the study noted that driving isn’t recommended during the initial weeks of treatment while patients adjust to the medication, but the low THC dose minimized impairment concerns.

Real-World Applications

These study findings have significant implications for how we approach chronic back pain treatment. Currently, many patients cycle through various treatments—physical therapy, over-the-counter medications, prescription opioids, injections, and sometimes even surgery—often with limited success and substantial side effects.

Cannabis could fill an important gap in the treatment spectrum. For patients who haven’t found adequate relief from conservative treatments but want to avoid opioids, this could provide an effective middle-ground option. The medication’s favorable safety profile makes it particularly attractive for long-term management of chronic conditions.

The standardized, pharmaceutical-grade nature of the extract used in this study is important for real-world application. Unlike products available at dispensaries, which can vary widely in potency and composition, a standardized medication ensures consistent dosing and predictable effects. This consistency is essential for both doctors prescribing the medication and patients relying on it for daily pain management.

Healthcare providers could potentially use this treatment as part of a pain management strategy, possibly reducing the need for opioid prescriptions and their risks that come along with them. Cannabis ability to improve sleep and physical function alongside pain reduction

makes it particularly valuable for treating the multiple dimensions of chronic pain conditions.

The Larger Context of Cannabis as a Medicine

This study adds to growing evidence supporting cannabis as a legitimate medical treatment. Health officials in Canada and several European countries have already approved pharmaceutical-grade cannabis products for various types of pain, including nerve pain associated with multiple sclerosis. The FDA has approved CBD-based medications for treating rare forms of epilepsy in children.

However, cannabis remains federally illegal in the United States, creating barriers to research and medical access. This contradiction—where most states allow medical or recreational cannabis use while federal law prohibits it—complicates the development and approval of cannabis-based medicines.

The study’s publication in Nature Medicine, one of the world’s most known medical journals, also adds scientific credibility to cannabis research. High-quality evidence like this is essential for changing medical and regulatory attitudes toward cannabis-based treatments.

For the millions of people living with chronic back pain, these findings offer genuine hope for a future of better treatment options. The study’s design and impressive results provide the kind of solid scientific evidence needed to change medical practice and potentially

influence policy decisions about cannabis-based medicine.

Follow and Like:

Instagram: @ruderequipment

LinkedIn: Ruder Equipment

Resources: